Related Experiment Video

Updated: Jun 25, 2026

Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells
07:12

Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells

Published on: September 9, 2021

Comparative analysis of the JAK/STAT signaling through erythropoietin receptor and thrombopoietin receptor using a

Hong-Hee Won1, Inho Park, Eunjung Lee

  • 1Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology, 373-1 Guseong-dong, Yuseong-gu, Daejeon 305-710, South Korea. honghee.won@gmail.com

BMC Bioinformatics
|February 12, 2009
PubMed
Abstract

Insights

Modeling the Janus kinase-signal transducer and activator of transcription (JAK/STAT) pathway reveals how receptor kinetics and the JAK2V617F mutation influence myeloproliferative disorders (MPD). This research clarifies JAK/STAT signaling in MPD pathogenesis.

Area of Science:

  • Biochemistry
  • Systems Biology
  • Molecular Biology

Background:

  • The Janus kinase-signal transducer and activator of transcription (JAK/STAT) pathway is a key target in myeloproliferative disorders (MPD).
  • Previous systems biology models have advanced understanding, but lacked detailed investigation into pathological contexts, receptor kinetics, and mutation effects.

Purpose of the Study:

  • To model the JAK/STAT pathway, incorporating receptor kinetics and the JAK2V617F mutation.
  • To investigate the impact of receptor kinetics and mutations on JAK/STAT signaling in MPD.

Main Methods:

  • Performed computational modeling and simulation studies of the JAK/STAT pathway.
  • Included kinetics of the erythropoietin receptor and thrombopoietin receptor.
  • Analyzed both wild-type and JAK2V617F mutated JAK2 protein.

Main Results:

  • Identified differential kinetics of the erythropoietin and thrombopoietin receptors as potentially crucial for JAK/STAT signaling sensitivity to mutations.
  • Simulation results align with observed clinical pathological differences in MPD subtypes carrying the JAK2V617F mutation.

Conclusions:

  • Receptor kinetics play a significant role in modulating the JAK/STAT pathway's response to the JAK2V617F mutation.
  • The modeling approach supports understanding the molecular basis for distinct MPD subtypes associated with the JAK2V617F mutation.

More Related Videos

Mouse Fetal Liver Culture System to Dissect Target Gene Functions at the Early and Late Stages of Terminal Erythropoiesis06:40

Mouse Fetal Liver Culture System to Dissect Target Gene Functions at the Early and Late Stages of Terminal Erythropoiesis

Published on: September 9, 2014

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...